Probiotics may help with the gastrointestinal adjustment that occurs when stopping GLP-1 therapy
Parties Debate Adequacy of GLP-1 Label Warnings On April 9, lawyers representing the drug makers and plaintiffs involved in the litigation each submitted position papers to Judge Pratter, explaining their differing opinions on the litigation, which will largely focus on whether the label warnings for Ozempic, Mounjaro, Wegovy and Zepbound adequately disclosed the risks of gastroparesis and other intestinal injuries
Researchers found that patients meeting these criteria often experienced meaningful weight loss and improvements in obesity-related health risks
use other medicines that contain bupropion such as WELLBUTRIN, WELLBUTRIN SR, WELLBUTRIN XL, APLENZIN and ZYBAN
He added that if a company like Hims refused, it could face an enforcement action from the FDA or a lawsuit on day 61. As of publication, the FDA lists the majority of doses for Novos semaglutide drug (Ozempic, Wegovy, or Rybelsus) as available. Eli Lillys tirzepatide (Mounjaro) is in limited availability across several doses
One limitation worth stating plainly: this option currently exists only for the semaglutide family